Tafasitamab Biosimilar

CAT: 1601-CBA1075-01Size: 0.1 mgDry Ice: NoHazardous: No
CAT#:1601-CBA1075-01Size:0.1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Anti-CD19 [Tafasitamab]
Product Name Alternative
B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD19
Reactivity
H
Clonality
Monoclonal
Source
Humanized
Applications
Functional Assay
Purification
Affinity Chromatography
Form
IgG1 CH1-IgG2 FC, liquid in 10 mmol/L PBS, pH 7.2
Storage Conditions
Stored at 2-8°C for at least 4 weeks. Store at -20 °C for 12 months. For long term storage aseptically aliquot and store at -80°C. Avoid repeated freeze/thaw cycles.
NCBI Gene Symbol
CD19
SwissProt (Human)
P15391
Entrez GeneHuman
930

Related Products

CatalogName
CBA1014-01Trastuzumab Biosimilar
CBA1020-01Alirocumab Biosimilar
CBA1024-01Atezolizumab Biosimilar
CBA1025-01Avelumab Biosimilar
CBA1031-01Aducanumab Biosimilar
CBA1032-01Anumigilimab Biosimilar
CBA1034-01Avizakimab Biosimilar
CBA1035-01Benralizumab Biosimilar
CBA1038-01Brentuximab Biosimilar
CBA1040-01Camoteskimab Biosimilar

Alternative Products

CatalogName
ABS-216-100ugTafasitamab Biosimilar, Research Grade
ICH5132-50mgTafasitamab Biosimilar - Research Grade
A138573Tafasitamab Biosimilar (Monoclonal, IgG1)
MBS1881744-01Anti-CD19 (tafasitamab biosimilar) mAb
ICH5132UL-10mgTafasitamab Biosimilar - Ultra Low Endotoxin
BIO0002SM-20mgAnti-human CD19 (Tafasitamab Biosimilar)
10-676Tafasitamab (CD19) - Research Grade Biosimilar
RA0076-01Tafasitamab (Biosimilar Reference Antibody) (CD19)

Popular Products